Related Experiment Video
Updated: Feb 21, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs
Jingyin Yue1, Fan Lai1, Felipe Beckedorff1
1Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Abstract:
Activating mutations in the mitogen-activated protein kinase (MAPK) cascade, also known as the RAS-MEK-extracellular signal-related kinase (ERK1/2) pathway, are an underlying cause of >70% of human cancers. While great strides have been made toward elucidating the cytoplasmic components of MAPK signaling, the key downstream coactivators that coordinate the transcriptional response have not been fully illustrated. Here, we demonstrate that the MAPK transcriptional response in human cells is funneled through Integrator, an RNA polymerase II-associated complex. Integrator depletion diminishes ERK1/2 transcriptional responsiveness and cellular growth in human cancers harboring activating mutations in MAPK signaling. Pharmacological inhibition of the MAPK pathway abrogates the stimulus-dependent recruitment of Integrator at immediate early genes and their enhancers. Following epidermal growth factor (EGF) stimulation, activated ERK1/2 is recruited to immediate early genes and phosphorylates INTS11, the catalytic subunit of Integrator. Importantly, in contrast to the broad effects of Integrator knockdown on MAPK responsiveness, depletion of a number of critical subunits of the coactivator complex Mediator alters only a few MAPK-responsive genes. Finally, human cancers with activating mutations in the MAPK cascade, rendered resistant to targeted therapies, display diminished growth following depletion of Integrator. We propose Integrator as a crucial transcriptional coactivator in MAPK signaling, which could serve as a downstream therapeutic target for cancer treatment.
Insights
Integrator, a key complex in cellular signaling, acts downstream of the RAS-MEK-extracellular signal-related kinase (ERK1/2) pathway. Its depletion reduces cancer cell growth, suggesting Integrator as a potential therapeutic target for MAPK-driven cancers.
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Regulation
Background:
- Activating mutations in the mitogen-activated protein kinase (MAPK) cascade drive over 70% of human cancers.
- While MAPK pathway components are well-studied, downstream transcriptional coactivators remain less understood.
Purpose of the Study:
- To identify and characterize the key downstream coactivators coordinating the transcriptional response in the MAPK signaling pathway.
- To investigate the role of the Integrator complex in MAPK-driven transcriptional regulation and cancer growth.
Main Methods:
- Depletion of Integrator complex subunits using knockdown techniques.
- Pharmacological inhibition of the MAPK pathway.
- Analysis of gene expression changes and protein phosphorylation following epidermal growth factor (EGF) stimulation.
- Comparison with the effects of Mediator complex subunit depletion.
Main Results:
- Integrator depletion significantly reduces ERK1/2 transcriptional responsiveness and cancer cell growth in MAPK-mutated cancers.
- Activated ERK1/2 phosphorylates INTS11, the Integrator catalytic subunit, upon EGF stimulation.
- Integrator recruitment to immediate early genes and enhancers is abrogated by MAPK pathway inhibition.
- Integrator depletion impacts MAPK-responsive genes more broadly than Mediator subunit depletion.
Conclusions:
- The Integrator complex is a crucial transcriptional coactivator in the MAPK signaling pathway.
- Integrator plays a significant role in the growth of human cancers with activating MAPK mutations, including those resistant to targeted therapies.
- Integrator represents a promising downstream therapeutic target for treating MAPK-driven cancers.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
10:46Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
Published on: June 2, 2018
Related Concept Videos
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
RNA Polymerase II Accessory Proteins